Skip to NavigationSkip to content

News

A research letter published this week has suggested that the FDA initiatives to accelerate drug approvals in the US could have shaved up to almost...
A Phase 3 trial looking at the use of Kisqali to treat premenopausal or perimenopausal women with hormone-receptor positive, human epidermal growth...
Roche has unveiled new Phase 3 data showing that its haemophilia A treatment Helimbra produced clinically meaningful control of bleeding in...
Disulfiram has been known as an anti-drinking compound for nearly seven decades. Initially, the compound was used in the vulcanisation of tires but...
Bioethics international, a non-profit organisation, has published its second annual index ranking pharma companies by the transparency of data from...
Galectin Therapeutics has seen its share value almost halve after its revealed that its experimental treatment for non-alcoholic steatohepatitis...
Two big pharma companies have been taken to court by the Australian Competition and Consumer Commission over allegations of falsely marketing their...
In the latest boost to the UK’s life sciences strategy, GSK has committed £40 million to its work identifying new drug targets – a welcome piece...
Novartis' Rydapt has been awarded marketing approval in Canada for the treatment of FLT3-mutated acute myeloid leukaemia. However, NICE saw fit to...
Veeva took the opportunity at its European Commercial & Medical Summit to reveal the latest upgrade to its Veeva CRM Engage platform, with the...
Mission Statement
Pharmafile.com is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for Pharmafile.com and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches